Clinical Trials Browser

Phase 1/2 × tocilizumab × Plasma cell × Clear all

NCT05583617 2026-03-06

PLYCOM

Phase 1/2 Recruiting

Multiple Myeloma

NCT05535244 2026-02-09

CAMMA 2

Phase 1/2 Active not recruiting

Multiple Myeloma